SHMT2 deficiency disrupts transcriptional regulation through homocysteine-mediated suppression of histone lactylation in Huntington’s disease models
Journal of Clinical Investigation · 01.05.2026 · 136 (9)
DOI: 10.1172/jci196094 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 10.03.2026. Verfasst von Mingqin Lu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurobiology, School of Basic Medical Sciences. Hauptthemen laut MEDLINE: Huntington Disease, Glycine Hydroxymethyltransferase, Histones, Homocysteine. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The National Key Research and Development Program of China, The National Natural Science Foundation of China.
Abstract (Originalsprache)
Huntington’s disease (HD) is a fatal neurodegenerative disorder characterized by progressive motor dysfunction, cognitive decline, and striatal neuron degeneration, primarily affecting medium spiny neurons (MSNs). Despite extensive research, the underlying metabolic vulnerabilities contributing to HD pathogenesis remain poorly understood. In this study, we employed RNA-seq and metabolomics analyses to identify marked dysregulation of 1-carbon metabolism in HD. We validated that SHMT2, a key mitochondrial enzyme in the mitochondrial 1-carbon pathway, was substantially downregulated in HD patient–derived iPSC-differentiated human striatal organoids (hSOs) and YAC128 mice. Functionally, pharmacologic inhibition or genetic deletion of SHMT2 exacerbated mutant huntingtin aggregation, induced MSN degeneration in hSOs, and impaired motor function in WT mice. Conversely, SHMT2 overexpression attenuated MSN degeneration in HD-hSOs and improved motor performance in YAC128 mice. Mechanistically, SHMT2 deficiency led to accumulation of homocysteine, which interacted with AARS1 and suppressed histone lactylation, thereby perturbing transcriptional regulation and associating with neurodegenerative phenotypes. Finally, we demonstrated that the HD clinical drug haloperidol modulated SHMT2 expression and restored histone lactylation, providing a pharmacologic tool to probe SHMT2-dependent metabolic and epigenetic regulation in HD models. These findings highlight a metabolic-epigenetic axis as a promising therapeutic target for HD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurobiology, School of Basic Medical Sciences.
- State Key Laboratory of Reproductive Medicine and Offspring Health, and.
- Institute for Stem Cell and Neural Regeneration, School of Pharmacy, Nanjing Medical University, Nanjing, Jiangsu, China.
- Key Laboratory of Clinical Neurology, Ministry of Education, Hebei Medical University, Shijiazhuang, Hebei, China.
- Department of Neurology, Key Neurological Laboratory of Hebei Province, the Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
- Jiangsu Key Laboratory of Molecular Targets and Intervention for Metabolic Diseases, Nanjing Medical University, Nanjing, Jiangsu, China.
Förderung
- The National Key Research and Development Program of China
- The National Natural Science Foundation of China
Zitieren
APA
Lu, M., Li, K., Wu, S., Zheng, Z., Li, X., Wang, S., Yu, H., Liu, C., Jiang, Y., Song, X., Liu, Y., & Guo, X. (2026). SHMT2 deficiency disrupts transcriptional regulation through homocysteine-mediated suppression of histone lactylation in Huntington’s disease models. Journal of Clinical Investigation, 136(9). https://doi.org/10.1172/jci196094
Vancouver
Lu M, Li K, Wu S, Zheng Z, Li X, Wang S, et al. SHMT2 deficiency disrupts transcriptional regulation through homocysteine-mediated suppression of histone lactylation in Huntington’s disease models. Journal of Clinical Investigation. 2026;136(9). doi:10.1172/jci196094
BibTeX
@article{Lu2026,
author = {Lu, Mingqin and Li, Kexin and Wu, Shanshan and Zheng, Zhilong and Li, Xinyue and Wang, Shengda and Yu, Hanwen and Liu, Chunyue and Jiang, Yueqing and Song, Xueqin and Liu, Yan and Guo, Xing},
title = {SHMT2 deficiency disrupts transcriptional regulation through homocysteine-mediated suppression of histone lactylation in Huntington’s disease models},
journal = {Journal of Clinical Investigation},
year = {2026},
volume = {136},
number = {9},
doi = {10.1172/jci196094}
}
EUVIMED